Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study - Wikidata - wikimedia - TriplyDB

Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study

Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study

http://www.wikidata.org/entity/Q34484483

about

Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients.Rate of initial highly active anti-retroviral therapy regimen change and its predictors among adult HIV patients at University of Gondar Referral Hospital, Northwest Ethiopia: a retrospective follow up study Effectiveness of second-line antiretroviral therapy: the impact of drug switches.Incidence and risk factors of first-line antiretroviral treatment failure among human immunodeficiency virus-infected children in Amhara regional state, Ethiopia: a retrospective follow-up study.

P2860

Q36426953-F34D35AF-FB17-48A4-BE27-F49D678D6E40 Q36587875-ADBC157D-278C-4500-8CFA-C2E43C6322C5 Q38377004-BD59DF7F-1AEE-4079-A63A-D9703DA7BAAD Q52601719-087BFB81-F6BC-4E43-A218-CF674228AAC7

P2860

Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study

http://www.wikidata.org/entity/Q34484483

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Incidence and predictors of re ...... py in Thailand: a cohort study

@ast

Incidence and predictors of re ...... py in Thailand: a cohort study

@en

Incidence and predictors of re ...... py in Thailand: a cohort study

@nl

type

label

Incidence and predictors of re ...... py in Thailand: a cohort study

@ast

Incidence and predictors of re ...... py in Thailand: a cohort study

@en

Incidence and predictors of re ...... py in Thailand: a cohort study

@nl

prefLabel

Incidence and predictors of re ...... py in Thailand: a cohort study

@ast

Incidence and predictors of re ...... py in Thailand: a cohort study

@en

Incidence and predictors of re ...... py in Thailand: a cohort study

@nl

P1433

Q34484483-05D333DC-A20A-4E0D-9249-119DE948A144

P1476

Q34484483-4E32B226-BFF0-4323-B0B1-C2F860EAD869

P2093

Q34484483-3D4E6B7A-9EA0-4F8C-B392-016FB5CE3E4E

Q34484483-3E97E2D4-47B9-44A5-BE04-702B28EA057F

Q34484483-7CF4494B-D06D-40C8-A5FB-3AB4480DACB9

Q34484483-915F4AD4-B883-4964-9115-63FA333EC0EF

Q34484483-9BBB8EEF-1A03-4047-B075-5C981EC28F18

Q34484483-9E7A3D60-9B94-40AD-AD30-1CA5C89CD0C8

Q34484483-D616D898-8097-44F9-9722-2D6BE493E173

P2860

Q34484483-0B0F0CB5-4A8E-402F-B440-B2F0E6031A95

Q34484483-1F34DAB1-8C33-4CBF-8F7A-9DBACD41C5D9

Q34484483-3225CC17-65D8-4522-8822-29E821A1F2BE

Q34484483-48C5DDCE-0E06-454E-812E-28F0E76BA824

Q34484483-4A55D1C7-B3F2-46D2-A94B-A4ACF18FC5AB

Q34484483-4D07B20C-4358-484D-ADC7-627B3E6169D5

Q34484483-530A5D64-C861-4DC6-9194-CDA07D0DB602

Q34484483-5FE9C0DA-30E9-4E03-921C-4F785F4ED359

Q34484483-67930158-FD70-4188-8CC9-D4DF855C300B

Q34484483-73F05630-2EF8-47C5-93A9-1178E254235E

P2888

Q34484483-B9985082-F9E9-439A-BC73-F16D376AE8B4

P304

Q34484483-1DF59C0E-69D2-497C-AACA-1170FA0E5976

P31

Q34484483-C0DD1280-817C-4597-85FF-A1DE02B38031

P356

Q34484483-11F495E9-97FA-42E1-A20B-CD4F4161373F

P478

Q34484483-1C7F53F0-D72A-4C4C-B06A-68E7E2D2D4E8

P577

Q34484483-CD37FBAB-95A9-4484-B543-CC4EB029CD01

P5875

Q34484483-C10F74E3-4A94-4EBB-8459-A29D535F585A

P6179

Q34484483-10748BE8-8AC8-4D93-9065-2DB53E80D22C

P698

Q34484483-2970EA15-1411-4281-BAF3-F2DC58534BD6

P921

Q34484483-D50A3C0C-C036-4D47-8976-467707AC5584

Q34484483-EFAB6088-93DE-4B36-A670-1C41E57D598F

P932

Q34484483-CC5DDCD3-F2F3-42E4-94C6-87E4156E7ED9

P356

S12879-014-0565-5

P1433

BMC Infectious Diseases

P1476

Incidence and predictors of re ...... py in Thailand: a cohort study

@en

P2093

Archawin Rojanawiwat

http://www.w3.org/2001/XMLSchema#string

Koya Ariyoshi

http://www.w3.org/2001/XMLSchema#string

Naho Tsuchiya

http://www.w3.org/2001/XMLSchema#string

Nuanjun Wichukchinda

http://www.w3.org/2001/XMLSchema#string

Panita Pathipvanich

http://www.w3.org/2001/XMLSchema#string

Pathom Sawanpanyalert

http://www.w3.org/2001/XMLSchema#string

Wattana Auwanit

http://www.w3.org/2001/XMLSchema#string

P2860

Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.

Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.

Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen.

Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study.

HLA-B*5701 screening for hypersensitivity to abacavir.

Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level.

Individualization of antiretroviral therapy.

Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa.

P2888

s12879-014-0565-5

P304

565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12879-014-0565-5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267745840

http://www.w3.org/2001/XMLSchema#string

P6179

1006534533

http://www.w3.org/2001/XMLSchema#string

P698

25361850

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4226857

http://www.w3.org/2001/XMLSchema#string